Determinants of murein hydrolase targeting to cross-wall of Staphylococcus aureus peptidoglycan
about
Secreted Proteases Control Autolysin-mediated Biofilm Growth of Staphylococcus aureusProton-binding capacity of Staphylococcus aureus wall teichoic acid and its role in controlling autolysin activitySpoIVA and SipL are Clostridium difficile spore morphogenetic proteinsInteractions of the cell-wall glycopolymers of lactic acid bacteria with their bacteriophagesEngineering microbial surfaces to degrade lignocellulosic biomass.Cell wall structure and function in lactic acid bacteria.Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2011-2012.O-glycosylation as a novel control mechanism of peptidoglycan hydrolase activityAn intermolecular binding mechanism involving multiple LysM domains mediates carbohydrate recognition by an endopeptidase.Fusion with a cell wall binding domain renders autolysin LytM a potent anti-Staphylococcus aureus agent.Discovery of novel S. aureus autolysins and molecular engineering to enhance bacteriolytic activity.Methicillin resistance in Staphylococcus aureus requires glycosylated wall teichoic acidsSagB Glucosaminidase Is a Determinant of Staphylococcus aureus Glycan Chain Length, Antibiotic Susceptibility, and Protein Secretion.Staphylococcus aureus mutants lacking the LytR-CpsA-Psr family of enzymes release cell wall teichoic acids into the extracellular mediumGlycoepitopes of staphylococcal wall teichoic acid govern complement-mediated opsonophagocytosis via human serum antibody and mannose-binding lectinWall teichoic acids of gram-positive bacteria.Release of protein A from the cell wall of Staphylococcus aureus.The giant protein Ebh is a determinant of Staphylococcus aureus cell size and complement resistance.Lipoteichoic acids, phosphate-containing polymers in the envelope of gram-positive bacteria.Bacterial proteases: targets for diagnostics and therapy.Exploiting the peptidoglycan-binding motif, LysM, for medical and industrial applicationsSpatial Organization of Cell Wall-Anchored Proteins at the Surface of Gram-Positive Bacteria.Cell wall glycopolymers of Firmicutes and their role as nonprotein adhesins.The SPOR Domain, a Widely Conserved Peptidoglycan Binding Domain That Targets Proteins to the Site of Cell Division.Secretome analysis revealed adaptive and non-adaptive responses of the Staphylococcus carnosus femB mutant.Dual Targeting of Cell Wall Precursors by Teixobactin Leads to Cell Lysis.Complete Reconstitution of the Vancomycin-Intermediate Staphylococcus aureus Phenotype of Strain Mu50 in Vancomycin-Susceptible S. aureusWall teichoic acids prevent antibody binding to epitopes within the cell wall of Staphylococcus aureus.Bacterial Cell Enlargement Requires Control of Cell Wall Stiffness Mediated by Peptidoglycan Hydrolases.A Lactococcus lactis expression vector set with multiple affinity tags to facilitate isolation and direct labeling of heterologous secreted proteins.A novel type of peptidoglycan-binding domain highly specific for amidated D-Asp cross-bridge, identified in Lactobacillus casei bacteriophage endolysins.Human antibody responses against non-covalently cell wall-bound Staphylococcus aureus proteins.LysMD3 is a type II membrane protein without an in vivo role in the response to a range of pathogens.Release of Staphylococcus aureus extracellular vesicles and their application as a vaccine platform.Antibacterial fatty acids destabilize hydrophobic and multicellular aggregates of biofilm in S. aureus.Surfaceome and Proteosurfaceome in Parietal Monoderm Bacteria: Focus on Protein Cell-Surface Display.
P2860
Q27679788-FA19474D-69A9-4A13-93EB-58185D9AA054Q28481453-E0B3CD5E-513E-4161-BDF3-F71100490A01Q28485783-10CE89DA-6580-4351-BB53-D7918FFFF9ABQ33659328-EDDC7FB4-F7F7-4945-BCDA-9DB2B9983892Q33728270-DE30DAB4-A3FB-4B2F-B1A9-A362279A5A3DQ34139858-DCD6569A-901F-4BB6-AEEB-7F2CEC24FFA9Q34489424-2FAAE86B-FA4B-44AB-8938-B179D1A6741DQ34768929-55A9EAB2-F6BA-4C21-A0E0-B67EF17E8030Q35167687-BC5FE45D-1AE2-4836-B862-563D00BCCD5AQ35653429-01A516C1-D55E-4F99-A572-6AE915D9B18AQ35842148-39523594-4798-4A8A-AAE6-272A31061B46Q36414751-B2C2F3F0-6954-454C-A6B2-CABFE728B31CQ36709423-188F4508-25E4-4080-B25A-8D6D71BF74F1Q37253009-57992BAB-28B6-4A04-86AF-2343EAEE751EQ37312140-30D9017C-E7B2-4A62-94B6-B10C13D79A76Q37442758-D831485D-47FB-4528-B187-8B2682D48185Q37543679-A70F4C76-0B48-4566-85AA-222978EAC609Q37643393-E3628C83-1C9C-4AB4-B0DE-8B7DE54A2A31Q37643417-352594BC-4850-4D2D-9226-ED8BE282CC5FQ38188864-D5746106-5BA4-4B8D-87E5-08BBCAF780D9Q38197928-2BC8CBA4-5B1D-4FB4-A7DC-05FB52562FD8Q38792751-2065E36B-03B0-495D-97B4-ECB121FEEEDEQ38891513-DE27E4D6-0029-4692-9D65-D1A260D43B2DQ39232926-B78D853A-DE1B-4F19-BCF5-3C6569BDF964Q39958312-6C259373-E4B5-4498-A051-3F07EEEA01C3Q40566928-211912A0-E05B-4A1D-9675-09ADCB8350D2Q40719288-39EE3D01-E3A2-4D59-A059-21E67B2E0FEFQ40937001-38A0EA15-B3B3-43E0-B52F-1D66F62C98EFQ41084911-F7F7EAD1-BE6E-4013-B127-E19CDF2EECCCQ41925794-8FF97DDD-A9F8-4729-85CE-772CC11716CAQ42732752-D30EEF57-C983-4DF9-A451-B5E90AF1094BQ49830644-7277BDE9-1CC7-4411-9448-9892138D6231Q52678302-E4DC5FCC-B2C1-4ED1-AB48-124208FCD45BQ52719970-FFE58862-F1FA-4B94-9066-1EE277117A37Q53779476-C4D0A804-BCEB-4461-8597-01935AC619B2Q55404079-2C7E807B-9A8F-4267-B2B5-F9780F78E5DB
P2860
Determinants of murein hydrolase targeting to cross-wall of Staphylococcus aureus peptidoglycan
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Determinants of murein hydrola ...... ylococcus aureus peptidoglycan
@ast
Determinants of murein hydrola ...... ylococcus aureus peptidoglycan
@en
type
label
Determinants of murein hydrola ...... ylococcus aureus peptidoglycan
@ast
Determinants of murein hydrola ...... ylococcus aureus peptidoglycan
@en
prefLabel
Determinants of murein hydrola ...... ylococcus aureus peptidoglycan
@ast
Determinants of murein hydrola ...... ylococcus aureus peptidoglycan
@en
P2860
P356
P1476
Determinants of murein hydrola ...... ylococcus aureus peptidoglycan
@en
P2093
Matthew B Frankel
P2860
P304
10460-10471
P356
10.1074/JBC.M111.336404
P407
P577
2012-02-02T00:00:00Z